Approval

China clears Yiling's pediatric cold granules, a class 1 traditional Chinese medicine

Chinese regulators approved Yiling Pharmaceutical's Xiaoer Lianhua Ganmao granules for children aged 4 to 12 with common cold of the wind-heat type. The product is a new class 1 traditional Chinese medicine. Yiling also has other candidates in clinical testing and under marketing review.

Written by Gosset from public sources. Source types: News article. Sources are available to Gosset users. Log in to see them.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call